The first AI-designed drugs have ended with disappointment. Over the last year-plus, the first handful of molecules created by artificial intelligence have failed trials or been deprioritized. The AI companies behind these drugs brought them into the clinic full of fanfare about a new age of drug discovery — and have quietly shelved them after … Continue reading First AI-designed drugs fall short in the clinic, following years of hype